Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
Key Points
Key points are not available for this paper at this time.
Abstract
NCT01230827; Results.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial | Synapse